Treatment of gastrointestinal cytomegalovirus infection with twice- daily foscarnet: A pilot study of safety, efficacy, and pharmacokinetics in patients with AIDS

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 6, 1997, Pages 1226-1230

  Dieterich, Douglas T ^a   Poles, Michael A ^b,e   Lew, Edward A ^b   Martin Munley, Sarah ^c   Johnson, Jeanne ^c   Nix, David ^d   Faust, Michael J ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Astra USA   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOSCARNET; GANCICLOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; CREATININE CLEARANCE; CYTOMEGALOVIRUS; DRUG CLEARANCE; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SAFETY; GASTROINTESTINAL INFECTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NEPHROTOXICITY; PRIORITY JOURNAL; QUALITY OF LIFE;

EID: 0030950677     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.6.1226     Document Type: Article

References (15)

1. Åkesson-Johnasson, A., J.-O. Lernestedt, O. Ringden, B. Lonnqvist, and B. Wahren. 1986. Sensitivity of cytomegalovirus to intravenous foscarnet treatment. Bone Marrow Transplant. 1:215-220.
2. Aweeka, F., J. Gambertoglio, J. Mills, and M. A. Jacobson. 1989. Pharmacokinetics of intermittently administered intravenous foscarnet in the treatment of acquired immunodeficiency syndrome patients with serious cytomegalovirus retinitis. Antimicrob. Agents Chemother. 33:742-745.
3. Blanshard, C., Y. Benhamou, E. Dohin, J.-O. Lernstedt, B. G. Gazzard, and C. Katlama. 1995. Treatment of AIDS-associated gastrointestinal cytomegalovirus infection with foscarnet and ganciclovir: a randomized comparison. J. Infect. Dis. 172:622-628.
4. Centers for Disease Control. 1985. Revision of the case definition of acquired immunodeficiency syndrome for national reporting - United States. Morbid. Mortal. Weekly Rep. 34:373-375.
5. Connolly, G. M., M. Youle, and B. G. Gazzard. 1989. Foscarnet in the treatment of cytomegalovirus infection of the gut in patients with acquired immunodeficiency syndrome. Gut 30:5.
6. Deray, G., F. Martinez, C. Katlama, B. Levaltier, H. Beaufils, M. Danis, M. Rozenheim, A. Baumelou, E. Dohin, and M. Gentilini. 1989. Foscarnet nephrotoxicity: mechanisms, incidence and prevention. Am. J. Nephrol. 9:316-321.
7. Dieterich, D. T., M. A. Poles, M. Dicker, R. Tepper, and E. Lew. 1993. Foscarnet treatment of cytomegalovirus gastrointestinal infections in acquired immunodeficiency syndrome patients who have failed ganciclovir induction. Am. J. Gastroenterol. 88:542-548.
8. Dieterich, D. T., and M. Rahmin. 1991. Cytomegalovirus colitis in AIDS: presentation in 44 patients and a review of the literature. J. Acquired Immune Defic. Syndr. 4:S29-S35.
9. Hing, M. C., C. Goldschmidt, J. M. Mathijs, A. L. Cunningham, and D. A. Cooper. 1992. Chronic colitis associated with human immunodeficiency virus infection. Med. J. Aust. 156:683-687.
10. Katlama, C., E. Dohin, E. Caumes, I. Cochereau-Massin, C. Brancon, M. Robinet, O. Rogeaux, R. Dahan, and M. Gentilini. 1992. Foscarnet induction therapy for cytomegalovirus retinitis in AIDS: comparison of twice-daily and three-times-daily regimens. J. Acquired Immune Defic. Syndr. 5(Suppl. 1): S18-S24.
11. Kotler, D. P., S. Reka, and F. Clayton. 1993. Intestinal mucosal inflammation associated with human immunodeficiency virus infection. Dig. Dis. Sci. 38: 1119-1127.
12. Nelson, M. R., G. M. Connolly, D. A. Hawkins, and B. G. Gazzard. 1991. Foscarnet in the treatment of cytomegalovirus infection of the esophagus and colon in patients with the acquired immune deficiency syndrome. Am. J. Gastroenterol. 86:876-881.
13. Rotterdam, H., Y.-J. She, and D. T. Dieterich. 1989. Diagnosis and grading of CMV colitis: comparison of H&E stains, DNA in-situ hybridization, and immunoperoxidase stains for early and late antigens, abstr. M.P.B. 127, p. 243. In Abstracts of the 5th International Conference on AIDS. International Research Centre, Ottawa, Ontario, Canada.
14. Sjovall, J., A. Karlsson, S. Ogenstad, E. Sandstrom, and M. Saarimaki. 1988. Pharmacokinetics and absorption of foscarnet after intravenous and oral administration to patients with human immunodeficiency virus. Clin. Pharmacol. Ther. 44:65-73.
15. Weber, J. N., S. Thom, I. Barrison, R. Unwin, S. Forster, D. J. Jeffries, A. Boylston, and A. J. Pinching. 1987. Cytomegalovirus colitis and oesophageal ulceration in the context of AIDS. Clinical manifestations and a preliminary report of treatment with foscarnet (phosphonoformate). Gut 28:482-487.